World Health Organ Tech Rep Ser. 1998;882:1-77.
This report presents the recommendations of a WHO Expert Committee responsible for updating and revising the Model List of Essential Drugs. The first part provides guidance for countries wishing to establish national programmes for essential drugs, and includes discussion of quality assurance, essential drugs for primary health care, post-registration drug studies, drug information and educational activities, and research and development. In the light of increasing resistance to antimicrobials, particular attention is drawn to the need for and use of reserve antimicrobials. The second part presents the tenth revised model list, together with details of changes that have been made, a glossary of terms and an alphabetical list of all the drugs included.
本报告介绍了负责更新和修订基本药物示范目录的世界卫生组织专家委员会的建议。第一部分为希望建立国家基本药物规划的国家提供指导，内容包括质量保证、初级卫生保健的基本药物、注册后药物研究、药物信息与教育活动以及研究与开发。鉴于对抗微生物药物的耐药性不断增加，特别提请注意储备抗微生物药物的必要性和使用。第二部分列出了第十次修订的示范目录，以及所做更改的详细信息、术语表和所有列入药物的字母顺序清单。
